Ge Long Hui A P P·2025-08-29 06:47Core Viewpoint - The report from Cinda Securities indicates that Chenguang Biotech achieved a net profit attributable to shareholders of 215 million yuan, representing a year-on-year increase of 115.33% [1] Financial Performance - In Q2 2025, the net profit attributable to shareholders was 105 million yuan, showing a year-on-year growth of 72.25% [1] - The revenue performance remained stable with a significant increase in volume [1] Business Segments - In the plant extraction business, the sales volume of chili red reached 6,367 tons in the first half of the year, up 43% year-on-year [1] - Sales of chili essence were 1,536 tons, reflecting an 81% year-on-year increase [1] - Sales of feed-grade lutein exceeded 210 million grams, showing a slight year-on-year increase [1] - Sales of food-grade lutein reached 31.25 million grams, marking a 22% year-on-year growth [1] Future Outlook - The company is expected to continue achieving high year-on-year profit growth in the second half of the year, with attention on raw material harvest prices [1] - The profit in the second half of last year was affected by the cottonseed business, resulting in a low base for comparison [1] - Starting from Q3, raw materials such as marigold, pigment chili, and capsaicin will enter the harvest season, and their purchase prices will determine the company's product prices and gross margins for the next year [1]